Keyword: Biovail

  • Eugene Melnyk

    Biovail Fined; Melnyk Charges Remain

    Canadian drug maker Biovail Corp., which was formerly headed by prominent Thoroughbred owner-breeder Eugene Melnyk, agreed March 24 to pay a $10-million fine to resolve federal regulators' charges of civil accounting fraud and deceiving investors and analysts.

  • Melnyk Company Under SEC Investigation

    The U.S. Securities and Exchange Commission has opened an informal inquiry into the accounting and financial-reporting practices of Eugene Melnyk's pharmaceutical company Biovail Corp.